Skip to main content
Top
Published in: Current Pain and Headache Reports 7/2019

01-07-2019 | Opioids | Other Pain (A Kaye and N Vadivelu, Section Editors)

Comprehensive Perioperative Management Considerations in Patients Taking Methadone

Authors: Elyse M. Cornett, Ryan J. Kline, Spencer L. Robichaux, Jeremy B. Green, Boris C. Anyama, Sonja A. Gennuso, Eva C. Okereke, Alan D. Kaye

Published in: Current Pain and Headache Reports | Issue 7/2019

Login to get access

Abstract

Purpose of Review

Well-informed staff can help decrease risks and common misconceptions regarding opioid-tolerant patients, especially those taking methadone.

Recent Findings

In 2015, opioid pain relievers were the second most used drug at 3.8 million. Overdose death was three times greater in 2015 than in 2000. Medication-assisted treatment was sought by more than 2 million individuals with substance use disorder, one of which is methadone.

Summary

Chronic pain affects millions of adults in the USA. Opioid therapy is widely used among these adults. Related to the risk of abuse and dependence, guidelines suggest that opioid therapy may not be considered first-line treatment. A multidisciplinary approach, including thorough preoperative evaluation, the utilization of multimodal pain management strategies, and opioid-sparing techniques in both the intraoperative and postoperative periods will allow for the best possible outcome.
Literature
1.
go back to reference Cooney MF, Fnp-Bc K, Broglio A-B. Acute pain management in opioid-tolerant individuals. TJNP J Nurse Pract. 2017;13:394–9.CrossRef Cooney MF, Fnp-Bc K, Broglio A-B. Acute pain management in opioid-tolerant individuals. TJNP J Nurse Pract. 2017;13:394–9.CrossRef
2.
go back to reference Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. United States: NIH public Access. 2006;144:127–34.CrossRef Alford DP, Compton P, Samet JH. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. United States: NIH public Access. 2006;144:127–34.CrossRef
3.
go back to reference Hines S, Theodorou S, Williamson A, Fong D, Curry K. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev Wiley/Blackwell (10.1111). 2008;27:519–23.CrossRef Hines S, Theodorou S, Williamson A, Fong D, Curry K. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev Wiley/Blackwell (10.1111). 2008;27:519–23.CrossRef
4.
go back to reference Simpson G, Jackson M. Perioperative management of opioid-tolerant patients. BJA Educ Oxford University Press. 2017;17:124–8.CrossRef Simpson G, Jackson M. Perioperative management of opioid-tolerant patients. BJA Educ Oxford University Press. 2017;17:124–8.CrossRef
5.
go back to reference Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy. Anesthesiol Clin Elsevier. 2018;36:345–59.CrossRef Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy. Anesthesiol Clin Elsevier. 2018;36:345–59.CrossRef
6.
go back to reference Boer ME. Perioperative pain management in patients on opioid replacement therapy: an integrative review. 2017. Boer ME. Perioperative pain management in patients on opioid replacement therapy: an integrative review. 2017.
7.
go back to reference Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manag Dove Press. 2017;13:1163–73.CrossRef Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manag Dove Press. 2017;13:1163–73.CrossRef
8.
go back to reference Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care. 2011;39:804–23.CrossRef Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care. 2011;39:804–23.CrossRef
9.
go back to reference Kumar K, Kirksey MA, Duong S, Wu CL. A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively. Anesth Analg United States. 2017;125:1749–60.CrossRef Kumar K, Kirksey MA, Duong S, Wu CL. A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively. Anesth Analg United States. 2017;125:1749–60.CrossRef
10.
go back to reference American Society of Anesthesiologists, Sinatra RS, Mitra S, Raymond S. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology [American Society of Anesthesiologists, etc]. 2004;101:212–27. American Society of Anesthesiologists, Sinatra RS, Mitra S, Raymond S. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology [American Society of Anesthesiologists, etc]. 2004;101:212–27.
11.
go back to reference Peng PWH, Tumber PS, Gourlay D. Review article: Perioperative pain management of patients on methadone therapy. Can J Anesth. 2005;52:513–23.CrossRef Peng PWH, Tumber PS, Gourlay D. Review article: Perioperative pain management of patients on methadone therapy. Can J Anesth. 2005;52:513–23.CrossRef
12.
go back to reference Faul M, Bohm M, Alexander C. Methadone prescribing and overdose and the association with Medicaid preferred drug list policies — United States, 2007–2014. MMWR Morb Mortal Wkly Rep. 2017;66:320–3.CrossRef Faul M, Bohm M, Alexander C. Methadone prescribing and overdose and the association with Medicaid preferred drug list policies — United States, 2007–2014. MMWR Morb Mortal Wkly Rep. 2017;66:320–3.CrossRef
13.
go back to reference Brown R, Kraus C, Fleming M. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004;80:654–9.CrossRef Brown R, Kraus C, Fleming M. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004;80:654–9.CrossRef
14.
go back to reference Bryson EO. The perioperative management of patients maintained on medications used to manage opioid addiction. Curr Opin Anaesthesiol. 2014;27:359–64.CrossRef Bryson EO. The perioperative management of patients maintained on medications used to manage opioid addiction. Curr Opin Anaesthesiol. 2014;27:359–64.CrossRef
15.
go back to reference Krebs EE, Becker WC, Zerzan J, Bair MJ, McCoy K, Hui S. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain. 2011;152:1789–95.CrossRef Krebs EE, Becker WC, Zerzan J, Bair MJ, McCoy K, Hui S. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain. 2011;152:1789–95.CrossRef
16.
go back to reference Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76:370–82.CrossRef Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76:370–82.CrossRef
17.
go back to reference Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, et al. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist salvinorin a in humans. Biol Psychiatry. 2012;72:871–9.CrossRef Ranganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, et al. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist salvinorin a in humans. Biol Psychiatry. 2012;72:871–9.CrossRef
18.
go back to reference Bruchas MR, Land BB, Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314:44–55.CrossRef Bruchas MR, Land BB, Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314:44–55.CrossRef
19.
go back to reference Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483–8.CrossRef Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12:483–8.CrossRef
20.
go back to reference Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38:217–25.CrossRef Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38:217–25.CrossRef
21.
go back to reference Chu Sin Chung P, Kieffer BL. Delta opioid receptors in brain function and diseases. Pharmacol Ther. 2013;140:112–20.CrossRef Chu Sin Chung P, Kieffer BL. Delta opioid receptors in brain function and diseases. Pharmacol Ther. 2013;140:112–20.CrossRef
22.
go back to reference Pellissier LP, Pujol CN, Becker JAJ, Le Merrer J. Delta Opioid Receptors: learning and motivation. Handb Exp Pharmacol 2016. Pellissier LP, Pujol CN, Becker JAJ, Le Merrer J. Delta Opioid Receptors: learning and motivation. Handb Exp Pharmacol 2016.
23.
go back to reference Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol. 2013;4:132.CrossRef Iwaszkiewicz KS, Schneider JJ, Hua S. Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol. 2013;4:132.CrossRef
24.
go back to reference Kanjhan R. Opioids and pain. Clin Exp Pharmacol Physiol. 1995;22:397–403.CrossRef Kanjhan R. Opioids and pain. Clin Exp Pharmacol Physiol. 1995;22:397–403.CrossRef
25.
go back to reference Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The opioid crisis: a comprehensive overview. Curr Pain Headache Rep. 2018;22:16.CrossRef Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The opioid crisis: a comprehensive overview. Curr Pain Headache Rep. 2018;22:16.CrossRef
26.
go back to reference Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7:13–21.CrossRef Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7:13–21.CrossRef
27.
go back to reference Theisen K, Jacobs B, Macleod L, Davies B. The United States opioid epidemic: a review of the surgeon’s contribution to it and health policy initiatives. BJU Int. 2018;122:754–9.CrossRef Theisen K, Jacobs B, Macleod L, Davies B. The United States opioid epidemic: a review of the surgeon’s contribution to it and health policy initiatives. BJU Int. 2018;122:754–9.CrossRef
28.
go back to reference Manhapra A, Becker WC. Pain and addiction. Med Clin North Am. 2018;102:745–63.CrossRef Manhapra A, Becker WC. Pain and addiction. Med Clin North Am. 2018;102:745–63.CrossRef
29.
go back to reference Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician [Internet]. 2017 [cited 2018 Mar 14];20:S93–109. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28226333 Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician [Internet]. 2017 [cited 2018 Mar 14];20:S93–109. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​28226333
30.
go back to reference Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. Regulation of -opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65:223–54.CrossRef Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. Regulation of -opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65:223–54.CrossRef
31.
go back to reference Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 14:145–61. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 14:145–61.
32.
go back to reference CHU L, CLARK D, ANGST M. Opioid tolerance and hyperalgesia in chronic pain patients after one month of Oral morphine therapy: a preliminary prospective study. J Pain. 2006;7:43–8.CrossRef CHU L, CLARK D, ANGST M. Opioid tolerance and hyperalgesia in chronic pain patients after one month of Oral morphine therapy: a preliminary prospective study. J Pain. 2006;7:43–8.CrossRef
33.
go back to reference Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–8.CrossRef Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–8.CrossRef
34.
go back to reference Arout CA, Edens E, Petrakis IL, Sofuoglu M. Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations. CNS Drugs. 2015;29:465–86.CrossRef Arout CA, Edens E, Petrakis IL, Sofuoglu M. Targeting opioid-induced hyperalgesia in clinical treatment: neurobiological considerations. CNS Drugs. 2015;29:465–86.CrossRef
35.
go back to reference Kaye AD, Cornett EM, Hart B, Patil S, Pham A, Spalitta M, et al. Novel pharmacological nonopioid therapies in chronic pain. Curr Pain Headache Rep. 2018;22:31.CrossRef Kaye AD, Cornett EM, Hart B, Patil S, Pham A, Spalitta M, et al. Novel pharmacological nonopioid therapies in chronic pain. Curr Pain Headache Rep. 2018;22:31.CrossRef
36.
go back to reference Induru RR, Davis MP. Buprenorphine for neuropathic pain—targeting hyperalgesia. Am J Hosp Palliat Med. 2009;26:470–3.CrossRef Induru RR, Davis MP. Buprenorphine for neuropathic pain—targeting hyperalgesia. Am J Hosp Palliat Med. 2009;26:470–3.CrossRef
37.
go back to reference Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manag. 2001;21:255–64.CrossRef Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manag. 2001;21:255–64.CrossRef
38.
39.
go back to reference Welsh C, Valadez-Meltzer A. Buprenorphine: a (relatively) new treatment for opioid dependence. Psychiatry (Edgmont). 2005;2:29–39. Welsh C, Valadez-Meltzer A. Buprenorphine: a (relatively) new treatment for opioid dependence. Psychiatry (Edgmont). 2005;2:29–39.
40.
go back to reference Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med. 2002;3:339–48.CrossRef Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med. 2002;3:339–48.CrossRef
41.
go back to reference Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manag. 2005;29:297–326.CrossRef Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manag. 2005;29:297–326.CrossRef
42.
go back to reference Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnstein J, et al. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manag. 2004;28:517–25.CrossRef Karasz A, Zallman L, Berg K, Gourevitch M, Selwyn P, Arnstein J, et al. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manag. 2004;28:517–25.CrossRef
43.
go back to reference Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, et al. Clinical effectiveness and safety of intraoperative methadone in patients undergoing posterior spinal fusion surgery. Anesthesiology. 2017;126:822–33.CrossRef Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, et al. Clinical effectiveness and safety of intraoperative methadone in patients undergoing posterior spinal fusion surgery. Anesthesiology. 2017;126:822–33.CrossRef
44.
go back to reference Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, et al. Intraoperative methadone for the prevention of postoperative pain. Anesthesiology. 2015;122:1112–22.CrossRef Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, et al. Intraoperative methadone for the prevention of postoperative pain. Anesthesiology. 2015;122:1112–22.CrossRef
45.
go back to reference Sunilkumar M, Lockman K. Practical pharmacology of methadone: a long-acting opioid. Indian J Palliat Care. 2018;24:10.CrossRef Sunilkumar M, Lockman K. Practical pharmacology of methadone: a long-acting opioid. Indian J Palliat Care. 2018;24:10.CrossRef
46.
go back to reference Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacokinet. 2002;41:1153–93.CrossRef Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacokinet. 2002;41:1153–93.CrossRef
47.
go back to reference Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16:616–22.CrossRef Salpeter SR, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med. 2013;16:616–22.CrossRef
48.
go back to reference Sotgiu ML, Valente M, Storchi R, Caramenti G, Biella GEM. Cooperative N-methyl-d-aspartate (NMDA) receptor antagonism and μ-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain. Pharmacol Res. 2009;60:284–90.CrossRef Sotgiu ML, Valente M, Storchi R, Caramenti G, Biella GEM. Cooperative N-methyl-d-aspartate (NMDA) receptor antagonism and μ-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain. Pharmacol Res. 2009;60:284–90.CrossRef
49.
go back to reference Vetulani J. Drug addiction. Part III. Pharmacotherapy of addiction. Pol J Pharmacol. 53:415–34. Vetulani J. Drug addiction. Part III. Pharmacotherapy of addiction. Pol J Pharmacol. 53:415–34.
50.
go back to reference Wiles JR, Isemann B, Mizuno T, Tabangin ME, Ward LP, Akinbi H, et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr. 2015;167:1214–1220.e3.CrossRef Wiles JR, Isemann B, Mizuno T, Tabangin ME, Ward LP, Akinbi H, et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr. 2015;167:1214–1220.e3.CrossRef
51.
go back to reference Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9:73–83.CrossRef Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9:73–83.CrossRef
52.
go back to reference Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9:358–67.CrossRef Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9:358–67.CrossRef
53.
go back to reference Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Reports. 2016;65:1–49.CrossRef Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Reports. 2016;65:1–49.CrossRef
54.
go back to reference Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American pain society and college on problems of drug dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–37.CrossRef Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American pain society and college on problems of drug dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014;15:321–37.CrossRef
55.
go back to reference Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V. Methadone metabolism and drug-drug interactions: in vitro and in vivo literature Review. J Pharm Sci. 2018;107:2983–91.CrossRef Volpe DA, Xu Y, Sahajwalla CG, Younis IR, Patel V. Methadone metabolism and drug-drug interactions: in vitro and in vivo literature Review. J Pharm Sci. 2018;107:2983–91.CrossRef
56.
go back to reference Review M, Garg R, Hariharan UR. Concerns of addiction to anaesthesiologists in the perioperative period. 2015;2:9–11. Review M, Garg R, Hariharan UR. Concerns of addiction to anaesthesiologists in the perioperative period. 2015;2:9–11.
57.
go back to reference Macintyre PE. Safety and efficacy of patient-controlled analgesia. 2001;87.CrossRef Macintyre PE. Safety and efficacy of patient-controlled analgesia. 2001;87.CrossRef
58.
go back to reference Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg. 2003;96:789–95.CrossRef Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg. 2003;96:789–95.CrossRef
59.
go back to reference Macintyre P, Scott D, Schug S. Acute pain management: scientific evidence. 2010. Macintyre P, Scott D, Schug S. Acute pain management: scientific evidence. 2010.
60.
go back to reference Greenberg S. Opioid-induced ventilatory impairment: an ongoing APSF initiative - Anesthesia Patient Safety Foundation. Anesth Patient Saf Found Newsl. Greenberg S. Opioid-induced ventilatory impairment: an ongoing APSF initiative - Anesthesia Patient Safety Foundation. Anesth Patient Saf Found Newsl.
61.
go back to reference Ramaswamy S, Wilson JA, Colvin L. Non-opioid-based adjuvant analgesia in perioperative care. Contin Educ Anaesth Crit Care Pain Oxford University Press. 2013;13:152–7.CrossRef Ramaswamy S, Wilson JA, Colvin L. Non-opioid-based adjuvant analgesia in perioperative care. Contin Educ Anaesth Crit Care Pain Oxford University Press. 2013;13:152–7.CrossRef
62.
go back to reference Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007;104:1545–56.CrossRef Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg. 2007;104:1545–56.CrossRef
63.
go back to reference Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17:131–57.CrossRef Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17:131–57.CrossRef
64.
go back to reference de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage Elsevier. 1995;10:378–84.CrossRef de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage Elsevier. 1995;10:378–84.CrossRef
Metadata
Title
Comprehensive Perioperative Management Considerations in Patients Taking Methadone
Authors
Elyse M. Cornett
Ryan J. Kline
Spencer L. Robichaux
Jeremy B. Green
Boris C. Anyama
Sonja A. Gennuso
Eva C. Okereke
Alan D. Kaye
Publication date
01-07-2019
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 7/2019
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-019-0783-z

Other articles of this Issue 7/2019

Current Pain and Headache Reports 7/2019 Go to the issue

Hot Topics in Pain and Headache (N Rosen, Section Editor)

Platelet-Rich Plasma for the Treatment of Low Back Pain: a Comprehensive Review

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Cerebral Venous Thrombosis Headache

Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Diving Headache